Application of tyrosine kinase inhibitors of JAK/STAT pathway in Hodgkin lymphoma cell lines was accompanied by a strong antiproliferative effect and enhanced death [40], lending support to our hypothesis. Here, SOAT1 is linked to Hodgkins lymphoma.